tiprankstipranks
Advertisement
Advertisement

HK:3681 Stock Latest News

SinoMab Bioscience Clarifies Board Structure and Committee Roles
Company AnnouncementsSinoMab Bioscience Clarifies Board Structure and Committee Roles
17h ago
3681
SinoMab Shareholders Unanimously Approve All Resolutions, Add New Non-Executive Director
PremiumCompany Announcements
SinoMab Shareholders Unanimously Approve All Resolutions, Add New Non-Executive Director
18h ago
3681
SinoMab Showcases Promising Preclinical Data for Novel Antibody in Alopecia and Vitiligo
PremiumCompany Announcements
SinoMab Showcases Promising Preclinical Data for Novel Antibody in Alopecia and Vitiligo
30d ago
3681
SinoMab Sets 2026 AGM to Renew Board, Auditor and Share Capital Mandates
PremiumCompany Announcements
SinoMab Sets 2026 AGM to Renew Board, Auditor and Share Capital Mandates
2M ago
3681
SinoMab Starts Phase 2 Trial of IL‑25 Antibody SM17 in Chinese Atopic Dermatitis Patients
PremiumCompany Announcements
SinoMab Starts Phase 2 Trial of IL‑25 Antibody SM17 in Chinese Atopic Dermatitis Patients
2M ago
3681
SinoMab Updates Board and Committee Structure to Clarify Governance Roles
PremiumCompany AnnouncementsSinoMab Updates Board and Committee Structure to Clarify Governance Roles
2M ago
3681
SinoMab BioScience Announces Resignations of Two Non-Executive Directors
Premium
Company Announcements
SinoMab BioScience Announces Resignations of Two Non-Executive Directors
2M ago
3681
SinoMab Bioscience Sets Out Board and Committee Structure
Premium
Company Announcements
SinoMab Bioscience Sets Out Board and Committee Structure
2M ago
3681
SinoMab Reports Positive Phase 1 Data for Subcutaneous SM17 in China
PremiumCompany Announcements
SinoMab Reports Positive Phase 1 Data for Subcutaneous SM17 in China
3M ago
3681
SinoMab Grants 11.6 Million Share Options to Key Employees
PremiumCompany Announcements
SinoMab Grants 11.6 Million Share Options to Key Employees
3M ago
3681
SinoMab Narrows Loss as Key Antibody Programs Advance and Funding Base Expands
PremiumCompany Announcements
SinoMab Narrows Loss as Key Antibody Programs Advance and Funding Base Expands
3M ago
3681
SinoMab Ends Haikou Lease as It Shifts to Asset-Light Manufacturing Model
PremiumCompany Announcements
SinoMab Ends Haikou Lease as It Shifts to Asset-Light Manufacturing Model
3M ago
3681
SinoMab BioScience Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsSinoMab BioScience Sets March Board Meeting to Approve 2025 Annual Results
3M ago
3681
SinoMab’s New SM17 Trial Puts Atopic Dermatitis Back in Focus for HK:3681 Investors
Premium
Company Announcements
SinoMab’s New SM17 Trial Puts Atopic Dermatitis Back in Focus for HK:3681 Investors
3M ago
3681
SinoMab Wins China IND Nod to Expand SM17 Into Inflammatory Bowel Disease
Premium
Company Announcements
SinoMab Wins China IND Nod to Expand SM17 Into Inflammatory Bowel Disease
4M ago
3681
SinoMab’s SM17 IND Application for IBD Accepted by NMPA
PremiumCompany Announcements
SinoMab’s SM17 IND Application for IBD Accepted by NMPA
6M ago
3681
SinoMab Doses First Cohort with Subcutaneous SM17 in China Study
PremiumCompany Announcements
SinoMab Doses First Cohort with Subcutaneous SM17 in China Study
8M ago
3681
SinoMab BioScience Announces New Company Secretary Appointment
PremiumCompany Announcements
SinoMab BioScience Announces New Company Secretary Appointment
8M ago
3681
SinoMab BioScience Reports Key Progress in Clinical Trials for 2025
PremiumCompany Announcements
SinoMab BioScience Reports Key Progress in Clinical Trials for 2025
10M ago
3681
SinoMab Completes New Share Subscription to Raise HK$50.68 Million
PremiumCompany AnnouncementsSinoMab Completes New Share Subscription to Raise HK$50.68 Million
10M ago
3681
SinoMab BioScience Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
SinoMab BioScience Schedules Board Meeting to Review Interim Results
10M ago
3681
SinoMab Completes New Share Subscription to Boost Drug Development
Premium
Company Announcements
SinoMab Completes New Share Subscription to Boost Drug Development
10M ago
3681

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >